-
Notifications
You must be signed in to change notification settings - Fork 2
Description
A call to the CPIC database https://api.cpicpgx.org/v1/rpc/recommendation_lookup?diplotypelookup={%22SLCO1B1%22:%20{%2237%22:%201,%20%2215%22:%201}}&order=drugname does not return recommendations for Rosuvastatin.
I saw the statement “Prescribe desired starting dose and adjust doses of rosuvastatin based on disease-specific and population-specific guidelines. Prescriber should be aware of possible increased risk for myopathy especially for doses >20 mg” three times all realted to the SLCO1B1 decreased function alone or with ABCG2 normal function or decreased function in https://files.cpicpgx.org/data/guideline/publication/statins/2022/publication.pdf. Also, The diplotype *15/*37 in the REST call is defined as SLCO1B1 Decreased Function in the spreadsheet of SLCO1B1_Diplotype_Phenotype_Table.
cpic_db=# select * from recommendation_view where drugname='rosuvastatin'; returns 27 rows with lookup keys all combined with ABCG2 for example {"ABCG2": "Poor Function", "SLCO1B1": "Decreased Function"}. This explains why a recommendation for the drug rosuvastatin was not returned for SLCO1B1 alone.
This is related to the sertraline issue that we are discussing in #48. However, the table 2 in the guidelines listed the recommendation for SLCO1B1 decreased function alone in this case. It's combined with ABCG2 in table 5.
Can you please take a look to see if additional lookup keys for SLCO1B1 alone can be defined?